Sevoflurane
Sevoflurane is an inhaled general anesthetic used to start and maintain anesthesia during inpatient and outpatient surgery in adults and children.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 12 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Sevoflurane: Patient Information Guide
A plain-language walkthrough of Sevoflurane — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Sevoflurane is an inhaled general anesthetic supported by multiple FDA-approved products for the same core use.
- Sojourn (sevoflurane, USP) — induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery
- Ultane — induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery
- Sevoflurane (Volatile for Inhalation) — induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery
- Sevoflurane, USP — induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery
⚙️How it works▾
Sevoflurane is a halogenated volatile anesthetic — a liquid that becomes a breathable gas. Because it has very low solubility in blood, it moves quickly from the lungs into the bloodstream, bringing on anesthesia in roughly one minute. The depth of sedation tracks closely with the concentration being inhaled, so the anesthesia team can deepen or lighten it in real time. When the gas is turned off, it leaves the body mainly through the lungs, allowing patients to wake up relatively quickly.
Only about 5% of sevoflurane is broken down by the liver (via an enzyme called CYP2E1); one byproduct is inorganic fluoride, which peaks within two hours of finishing anesthesia and clears from the blood within 48 hours in most patients. Sevoflurane also reduces the heart's pumping strength in a dose-related way and does not significantly increase heart rate at typical anesthetic doses.
💊How it's taken▾
Sevoflurane is delivered as an inhaled gas through a specialized vaporizer attached to an anesthesia machine — always in a clinical setting by trained anesthesia professionals. The concentration is adjusted continuously based on each patient's response. It can be breathed in through a face mask to induce sleep before surgery, then continued through a breathing circuit to maintain anesthesia throughout the procedure.
- Surgical anesthesia is typically maintained at concentrations of 0.5–3% with or without nitrous oxide
- The required concentration decreases with age — older adults generally need less
- No specific pre-anesthetic medication is required or prohibited; the anesthesiologist decides based on the individual patient
🤒Side effects — in detail▾
Most side effects are mild, transient, and related to the surgery or the anesthetic process overall. Common ones include:
- Nausea and vomiting (very common after surgery)
- Low blood pressure (hypotension)
- Slow heart rate (bradycardia) or fast heart rate (tachycardia)
- Agitation on waking up — especially common in children
- Coughing, breath-holding, or brief airway spasm during mask induction
- Drowsiness and dizziness in the recovery room
- Shivering or feeling cold after surgery
Seek immediate medical attention for any signs of malignant hyperthermia (sudden high fever, muscle rigidity), seizures, or liver problems (jaundice, dark urine) after anesthesia — these are serious but rare reactions that require prompt treatment.
⚠️Warnings & precautions▾
- Malignant hyperthermia: A rare, life-threatening reaction causing extreme body temperature, muscle breakdown, and organ failure. Anyone with a known or suspected genetic risk must not receive sevoflurane.
- Seizures: Have been reported during and after sevoflurane anesthesia, most often in children and young adults, sometimes hours later. Some cases were confirmed by EEG.
- Kidney injury: Long or high-dose anesthesia at low fresh gas flow rates may produce a breakdown product (Compound A) that can potentially harm the kidneys. The anesthesia team manages flow rates to minimize this risk.
- Liver toxicity: Cases ranging from mild enzyme elevations to rare severe hepatic failure have been reported. Risk is higher in patients with pre-existing liver disease or who take other drugs affecting the liver.
- Fire hazard from dry CO₂ absorbent: Dry absorbent in the anesthesia machine can react violently with sevoflurane, causing extreme heat or fire. Anesthesia teams replace absorbent routinely to prevent this.
- Cardiovascular effects: Sevoflurane decreases the heart's output in a dose-related way; used with epinephrine it can trigger dangerous heart rhythm problems.
- Diffuse alveolar hemorrhage (lung bleeding): Rare but serious; reported as coughing up blood or sudden shortness of breath after exposure.
🔀What it interacts with▾
Sevoflurane interacts with several medications commonly used around the time of surgery — always give your anesthesia team a complete medication list.
- Epinephrine: Raises the risk of ventricular arrhythmias (dangerous heart rhythm problems); the team monitors heart rhythm closely if this combination is used
- Calcium channel blockers (e.g., verapamil): Can cause a marked drop in blood pressure and impair conduction between the heart's chambers
- MAO inhibitors: May cause unpredictable and dangerous blood pressure swings during surgery
- Nitrous oxide: Reduces the amount of sevoflurane needed; the team adjusts concentrations accordingly
- Nondepolarizing muscle relaxants (vecuronium, pancuronium, atracurium): Sevoflurane makes them stronger and longer-lasting; lower maintenance doses are usually required
- Benzodiazepines and opioids: Reduce the sevoflurane concentration needed to maintain anesthesia
- Isoniazid and chronic alcohol use: May increase how much sevoflurane is broken down by the liver, potentially increasing byproduct levels
- Drugs that can harm the liver: Concurrent use may increase the risk of liver injury; extra monitoring is warranted
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Do not receive sevoflurane if you or a close blood relative has a known or suspected risk of malignant hyperthermia
- Do not receive it if you have had a known allergic reaction to sevoflurane or another halogenated inhaled anesthetic
- Tell your anesthesia team about all prescription and over-the-counter medications, especially calcium channel blockers, MAO inhibitors, seizure medications, or blood thinners
- Tell the team about any history of liver disease or prior liver problems after anesthesia — including jaundice or hepatitis
- Tell the team about kidney disease or reduced kidney function
- Older adults need lower concentrations; the required anesthetic dose decreases with advancing age
- Premature infants: Safe dosing concentrations have not been established for premature neonates
- If you are pregnant or breastfeeding, discuss risks and benefits with your care team before receiving any general anesthetic
- Report any history of seizures — your team needs to know, as sevoflurane has been associated with post-operative seizures, particularly in younger patients
🚑If you take too much▾
If too much sevoflurane is given, the priority is to stop the drug immediately. The airway is kept open and breathing is supported with oxygen and assisted ventilation as needed, while the heart and circulation are monitored and supported.
Because sevoflurane leaves the body rapidly through the lungs, stopping the gas quickly is the most important step — which is why anesthesia professionals monitor drug levels continuously throughout every procedure.
📡Pharmacodynamics — effects in the body▾
Sevoflurane produces general anesthesia whose depth changes rapidly as the inhaled concentration is adjusted — making it very controllable. It causes a dose-related decrease in the heart's pumping strength and does not increase heart rate at doses below 2 MAC (the concentration needed to keep half of patients unresponsive to a surgical stimulus). In clinical studies, patients woke up and responded to commands faster with sevoflurane than with older agents like halothane or isoflurane, and recovery room discharge times were comparable to other modern anesthetics.
🔬Pharmacokinetics — how your body processes it▾
Sevoflurane's very low blood solubility means it rapidly equilibrates between the lungs and the bloodstream — anesthesia builds quickly (alveolar concentration reaches 50% of the inhaled dose in about one minute, versus 4–8 minutes for isoflurane) and clears quickly once stopped. Approximately 5% of a sevoflurane dose is metabolized by the liver enzyme CYP2E1 into a compound called hexafluoroisopropanol (HFIP) plus inorganic fluoride; HFIP is quickly processed and eliminated in the urine. Fluoride levels peak within 2 hours of finishing anesthesia and return to baseline within 48 hours in most patients, with a half-life of roughly 15–23 hours. The vast majority of sevoflurane is simply exhaled — that rapid lung elimination is what makes recovery so quick.
📦How to store it▾
Store at 20° to 25°C (68° to 77°F); excursions permitted to 15º to 30°C (59° to 86°F) .
📄 Written from Sevoflurane’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Sevoflurane — the kind of thing our pharmacy team would talk through with you at the counter.
What exactly is sevoflurane and why would my doctor use it instead of other anesthetics? ▾
What side effects should I expect after waking up from sevoflurane anesthesia? ▾
Are there any serious reactions I or my family should watch for after I get home? ▾
I've heard of something called malignant hyperthermia — should I be worried? ▾
Is it safe for my child to have sevoflurane anesthesia? ▾
Do my regular medications affect sevoflurane, and do I need to stop any before surgery? ▾
Is Sevoflurane available over the counter? ▾
When was Sevoflurane first available? ▾
Who makes Sevoflurane? ▾
💬 Answers drafted from Sevoflurane’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Sevoflurane comes
Sevoflurane is available in 2 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Inhalation solution (nebulizer)
How this form is used
- Sojourn is indicated for induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery
- Ultane is indicated for induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery
- Sevoflurane (Volatile for Inhalation) is indicated for induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery
- Sevoflurane (USP) is indicated for induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery
- Must be administered only by persons trained in the administration of general anesthesia using a vaporizer calibrated specifically for sevoflurane
- Sojourn and Ultane: the CO₂ absorbent should be replaced if there is any suspicion it has dried out, as dry absorbent can cause dangerous reactions with sevoflurane
- Sevoflurane has a mild, non-irritating odor and is suitable for mask induction in both adults and children
- Surgical anesthesia can usually be maintained with concentrations of 0.5–3% sevoflurane, with or without nitrous oxide, adjusted to each patient's response
Oral solution
📊 Sevoflurane across the U.S. market
How Sevoflurane appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Sevoflurane is used
A general measure of how commonly Sevoflurane is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Sevoflurane is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Sevoflurane prescribed? Of the 1,596 medications we measure, Sevoflurane ranks #928 by Medicaid prescriptions — more than 42% of them.
Utilization by Sevoflurane product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
sevoflurane 1000 MG/ML Inhalation Solution
Summed across the 6 of 22 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 200243
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Sevoflurane, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 6 of 22 listed Sevoflurane NDCs with Medicaid activity.
🔍 Compare Sevoflurane products
A representative set of FDA-listed product records for Sevoflurane — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Inhalation solution (nebulizer) | ||||
| 250 mL/250 mL | Respiratory (inhalation) | AbbVie Inc. × 4 listings | NDA | View NDC → |
| 250 mL/250 mL | Respiratory (inhalation) | Baxter Healthcare Company × 2 listings | ANDA | View NDC → |
| 250 mL/250 mL | Respiratory (inhalation) | Baxter Healthcare Corporation × 10 listings | ANDA | View NDC → |
| 1 mL/mL | Respiratory (inhalation) | Bryant Ranch Prepack | ANDA | View NDC → |
| 1 mL/mL | Respiratory (inhalation) | Halocarbon Life Sciences, LLC × 2 listings | ANDA | View NDC → |
| 250 mL/250 mL | Respiratory (inhalation) | Lannett Company, Inc. | ANDA | View NDC → |
| 250 mL/250 mL | Respiratory (inhalation) | Mullan Pharmaceutical Inc. | ANDA | View NDC → |
| 1 mL/mL | Respiratory (inhalation) | Piramal Critical Care Inc × 9 listings | ANDA | View NDC → |
| 250 mL/250 mL | Respiratory (inhalation) | Sandoz Inc. × 2 listings | ANDA | View NDC → |
| 250 mL/250 mL | Respiratory (inhalation) | Shandong New Time Pharmaceutical Co., Ltd. × 2 listings | ANDA | View NDC → |
| 💊Oral solution | ||||
| 500 L/500 L | — | Central Glass Co.,Ltd. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Halocarbon Life Sciences, LLC | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | BULK INGREDIENT | View NDC → |
| 1 mL/mL | — | Piramal Critical Care Inc × 2 listings | BULK INGREDIENT | View NDC → |
| 1 L/L | — | Shandong New Time Pharmaceutical Co., Ltd. | BULK INGREDIENT | View NDC → |
Showing 40 of 40 products — FDA National Drug Code Directory. See every product, package size and price: browse all 40 Sevoflurane NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Sevoflurane — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Sevoflurane in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Sevoflurane went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 36453 1 dose form · 1 strength
-
Dose form (SCDF) Inhalation Solution RxCUI 2108407In current FDA listingsClinical drug / strength (SCD) 1000 MG/MLRxCUI 200243
Look up RxCUI 36453 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Sevoflurane is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
RxNorm drug class
Sevoflurane belongs to the General Anesthetic class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 12 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. AbbVie Inc. is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.